ARCHIVES

In Brief: Wittes DCT Acting Deputy Director; Spallone Leaves For Fox Chase; Ronald Evens Heads AUR

This article is from The Cancer Letter archive.

Vol. 14 No. 26 | June 24, 1988

Download PDF Visit The Full Archive

Related Articles

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

Pill Associated With Cancer In BRCA1 Mutation Carriers

January 31, 2003

Viral Oncology Not Losing $5 Mil. This Year – But Watch Out for ‘79

January 6, 1978

NCI Plans To Expand CTSU Management Of Clinical Trials.

February 24, 2006

In Brief: O’Conor Names NCI Liaison To IARC, Saunders Acting IA Director Susan Sieber DCCP Deputy

May 27, 1983

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011